MedTrace Logo

Study to Evaluate Performance of the Organ Recovery Systems LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant

NCT03484455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2022-10-07

No results posted yet for this study

Summary

Comparison of hypothermic machine perfusion of livers to standard of care (static cold storage).

Conditions

  • Liver Transplantation

Interventions

DEVICE

Hypothermic machine perfusion

Organ Recovery Systems LifePort® Liver Transporter (LLT) System and Vasosol® Machine Perfusion Solution

DEVICE

Static cold storage

Static cold storage (standard of care)

Sponsors & Collaborators

  • Organ Recovery Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Stan Harris · Organ Recovery Systems

  • Matthew Copithorne · Organ Recovery Systems

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-03
Primary Completion
2022-07-12
Completion
2022-07-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03484455 on ClinicalTrials.gov